Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 3 October 2019




Time is life (Guest blog)
03 October 2019 - Martin Price

From a societal perspective, the new wave of personalised medicines and cell and gene therapies offer real hope to patients... Read more

Protecting European citizens against vaccine–preventable diseases
03 October 2019 - Magdalena R. de Azero

Vaccination certainly constitutes one of the most cost-effective health interventions existing today, preventing 2-3... Read more


Videos - Oncology Data Summit


Roberto Viola, Director General, DG CONNECT, European Commission
Read more

Nathalie Moll, Director General, EFPIA
Read more




Connecting Healthcare Debate
05 November 2019 (Residence Palace, Rue de la Loi 175, 1000 Brussels)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

14 October 2019 (New Cairo, Egypt)

The collaborative platform for connecting Regulatory experts in the Middle East Read more

LifeTime meets industry
31 October 2019 (Basel, Switzerland)

LifeTime is developing a Roadmap that will show the path on how technology developments will be combined with disease... Read more

Regenerative Medicine: Scientific Advances and Regulatory Framework in Europe
27 November 2019 (Brussels)

The aim of this workshop is to provide a comprehensive overview on scientific advances, ongoing clinical trials, regulatory... Read more


We published


Enabling self-efficacy through digital technologies and innovative therapies
01 October 2019 (Publications)

Patients have the tools to measure and record data and, increasingly, have access to innovative technologies and therapies... Read more


What we are reading


Why transparency in drug pricing is more complicated than it seems
On 01 October 2019 (World Economic Forum)

By Alexander Roediger, Chair of the EFPIA Oncology Platform. Read more

Official kick-off of the IMI2 JU 'Immune-Image’ project
On 01 October 2019 (

It will enable smart monitoring of immunotherapies and widespread usage of a personalised medicine approach. Read more